Bioasis Technologies, Inc.
Records under this name other than the patents Bioasis Technologies, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 4 patents it holds.
Showing 1 to 10 of 10 · Back to Bioasis Technologies, Inc.
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 10,058,619 | P97-Polynucleotide Conjugates Lapsed on the fee record Ended Aug 28, 2026 · High confidence | Lapsed on the fee record | Ended Aug 28, 2026 | High confidence |
| US 9,993,530 | Fragments of P97 and uses thereof Lapsed on the fee record Ended Jun 12, 2026 · From the USPTO record | Lapsed on the fee record | Ended Jun 12, 2026 | From the USPTO record |
| US 8,722,019 | P97 fragments with transfer activity Lapsed on the fee record Ended May 13, 2026 · From the USPTO record | Lapsed on the fee record | Ended May 13, 2026 | From the USPTO record |
| US 9,932,565 | Dephosphorylated lysosomal storage disease proteins and methods of use thereof Lapsed on the fee record Ended Apr 3, 2026 · From the USPTO record | Lapsed on the fee record | Ended Apr 3, 2026 | From the USPTO record |
| US 9,850,472 | P97-antibody conjugates and methods of use Lapsed on the fee record Ended Dec 26, 2025 · From the USPTO record | Lapsed on the fee record | Ended Dec 26, 2025 | From the USPTO record |
| US 11,124,781 | P97-IDS fusion proteins Lapsed on the fee record Ended Sep 21, 2025 · From the USPTO record | Lapsed on the fee record | Ended Sep 21, 2025 | From the USPTO record |
| US 11,034,943 | Dephosphorylated lysosomal storage disease proteins and methods of use thereof Lapsed on the fee record Ended Jun 15, 2025 · From the USPTO record | Lapsed on the fee record | Ended Jun 15, 2025 | From the USPTO record |
| US 10,772,939 | Fragments of P97 and uses thereof Lapsed on the fee record Ended Sep 15, 2024 · From the USPTO record | Lapsed on the fee record | Ended Sep 15, 2024 | From the USPTO record |
| US 9,364,567 | Fragments of p97 and uses thereof Lapsed on the fee record Ended Jun 14, 2024 · From the USPTO record | Lapsed on the fee record | Ended Jun 14, 2024 | From the USPTO record |
| US 8,546,319 | Use of p97 As An Enzyme Delivery System For The Delivery of Therapeutic Lysosomal Enzymes Formerly held Term ended Term ended Feb 20, 2024 · Medium confidence | Term ended | Term ended Feb 20, 2024 | Medium confidence |